Sphingolipids in Cancer, Volume 140, the latest release in the Advances in Cancer Research series, provides invaluable information on the exciting and fast-moving field of cancer research. Topics discussed in this updated volume include Mechanisms of ceramide-dependent cancer cell death, Sphingolipids as regulators of autophagy and endocytic trafficking, The role and function of sphingomyelin biosynthesis in the development of cancer, Neutral sphingomyelinases in cancer: Friend or foe?, Sphingolipid rendezvous at the crossroad of NAFLD and senescence, Ceramide signaling and p53 pathways, Sphingolipid regulation of RNA Biology in cancer phenotypes, The role of ceramide-1-phosphate in tumor cell survival and dissemination, and more.
- Provides information on cancer research, with this release focusing on sphingolipids
- Offers outstanding and original reviews on a range of cancer research topics
- Serves as an indispensable reference for researchers and students alike
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Rose Nganga, Natalia Oleinik and Besim Ogretmen
- Sphingolipids as regulators of autophagy and endocytic trafficking
Megan M. Young and Hong-Gang Wang
- Role and function of sphingomyelin biosynthesis in the development of cancer
Giovanni D'Angelo, Sitapriya Moorthi and Chiara Luberto
- Neutral sphingomyelinases in cancer: friend or foe?
Christopher J. Clarke
- Ceramide and exosomes: a novel target in cancer biology and therapy
Ahmed Elsherbini and Erhard Bieberich
- Sphingolipids at the crossroads of NAFLD and senescence
- Ceramide signaling and p53 pathways
Kristen Jeffries and Natalia Krupenko
- The role of ceramide 1-phosphate in tumor cell survival and dissemination
- The onus of sphingolipid enzymes in cancer drug resistance
Samy A.F. Morad and Myles C. Cabot
- Interdiction of sphingolipid metabolism revisited: focus on prostate cancer
Christina Voelkel-Johnson, James S. Norris and Shai White-Gilbertson
- Targeting sphingosine kinases for the treatment of cancer
Clayton S. Lewis, Christina Voelkel-Johnson and Charles D. Smith
- Novel sphingolipid-based cancer therapeutics in the personalized medicine era
Jeremy Shaw, Pedro Costa-Pinheiro, Logan Patterson, Kelly Drews, Sarah Spiegel and Mark Kester
- Side effects in cancer therapy: are sphingolipids to blame?
Falak Patel and Stefka D. Spassieva